Citation Impact
Citing Papers
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients
2023 StandoutNobel
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
Phenotypic and Functional Analysis of CD4+CD25−Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus
2009
Deficient CD4+CD25high T Regulatory Cell Function in Patients with Active Systemic Lupus Erythematosus
2007
IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells
2007
Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
2014
Re-establishing immunological self-tolerance in autoimmune disease
2012 StandoutNobel
A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients
2010
The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease
2006
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
2009 StandoutNobel
A Requisite Role for Induced Regulatory T Cells in Tolerance Based on Expanding Antigen Receptor Diversity
2011
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
2008
The quantitative analysis of peripheral blood FOXP3‐expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients
2007
Reduced CD4+,CD25− T cell sensitivity to the suppressive function of CD4+,CD25high,CD127−/low regulatory T cells in patients with active systemic lupus erythematosus
2008
Etiology of Sarcoidosis
2008
Regulatory T Cells and Immune Tolerance
2008 StandoutNobel
Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus
2008
Function of CD4+,CD25+ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen‐presenting cells and effector T cells
2008
Systemic sclerosis
2017 Standout
Global Impairment of CD4 + CD25 + FOXP3 + Regulatory T Cells in Idiopathic Pulmonary Fibrosis
2009
Regulatory T cells in patients with systemic lupus erythematosus
2006
Regulatory T Cells and Systemic Lupus Erythematosus
2006
Sarcoidosis
2013 Standout
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
2011 StandoutNobel
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
2009 StandoutNobel
Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning
2009
CD8+ Tregs in lupus, autoimmunity, and beyond
2010
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs
2010
The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies
2012
Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)
2008
Graft-versus-host disease
2009 Standout
T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development
2012 StandoutNobel
Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission
2007
CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas
2008
Ocular sarcoidosis
2012
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Inhaled Vasoactive Intestinal Peptide Exerts Immunoregulatory Effects in Sarcoidosis
2010
Cancer immunotherapy comes of age
2011 StandoutNature
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Clinical significance of increased CD4+CD25 Foxp3+ T cells in patients with new-onset systemic lupus erythematosus
2008
The plasticity and stability of regulatory T cells
2013 StandoutNobel
Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis
2007
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Role of regulatory T cells and FOXP3 in human diseases
2007
Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus
2010
TREG-cell therapies for autoimmune rheumatic diseases
2014 StandoutNobel
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Experimentally-Derived Fibroblast Gene Signatures Identify Molecular Pathways Associated with Distinct Subsets of Systemic Sclerosis Patients in Three Independent Cohorts
2015
Altered homeostasis of CD4+ FoxP3+regulatory T‐cell subpopulations in systemic lupus erythematosus
2008
Th17 and natural Treg cell population dynamics in systemic lupus erythematosus
2009
Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus
2010
Sarcoidosis
2007 Standout
Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases
2020 StandoutNobel
FoxP3+ Regulatory T Cells Suppress Early Stages of Granuloma Formation but Have Little Impact on Sarcoidosis Lesions
2009
T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus
2011
Pulmonary hypertension complicating sarcoidosis
2012
Development and Maintenance of Regulatory T cells
2013 StandoutNobel
Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon‐α–producing antigen‐presenting cells
2008
Association of Sarcoidosis and Immune Thrombocytopenia
2011
Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD‐1.3A genotype in patients with systemic lupus erythematosus
2010
Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus
2007
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Gene expression profiling offers insights into the role of innate immune signaling in SSc
2015
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus
2009
The numbers of Foxp3 + Treg cells are positively correlated with higher grade of infiltration at the salivary glands in primary Sjögren's syndrome
2009
Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 high regulatory T cells in humans
2015 StandoutNobel
Reduced Number and Function of CD4+ CD25 high FoxP3 + Regulatory T Cells in Patients with Systemic Lupus Erythematosus
2007
Regulatory T Cells and Human Disease
2020 StandoutNobel
Homeostasis of Thymus-Derived Foxp3+ Regulatory T Cells Is Controlled by Ultraviolet B Exposure in the Skin
2014 StandoutNobel
Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus
2007
Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model
2016 StandoutNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Sarcoidosis is a Th1/Th17 multisystem disorder
2010
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Anti-Programmed Cell Death 1 Antibody Reduces CD4+PD-1+ T Cells and Relieves the Lupus-Like Nephritis of NZB/W F1 Mice
2010 StandoutNobel
Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon
2012 StandoutNobel
Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis.
2010
Combination of IL-2, rapamycin, DNA methyltransferase and histone deacetylase inhibitors for the expansion of human regulatory T cells
2016 StandoutNobel
CD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice
2013
Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death
2006
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Conditional stability of T cells
2010 StandoutNatureNobel
Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors
2007 StandoutNobel
C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis.
2010
Natural regulatory T cells: mechanisms of suppression
2007 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Uncommon histiocytic disorders: Rosai–Dorfman, juvenile xanthogranuloma, and Erdheim–Chester disease
2015
Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus
2008
CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
2008 StandoutNobel
CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game
2011
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
2011 StandoutNobel
A distinct subpopulation of CD25−T-follicular regulatory cells localizes in the germinal centers
2017 StandoutNobel
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis
2008
Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice
2017 StandoutNobel
Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance
2008
Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody
2018 StandoutNobel
Works of S. Trad being referenced
The immune paradox of sarcoidosis and regulatory T cells
2006
Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease
2005
Variability in the efficacy of interferon‐α in Erdheim‐Chester disease by patient and site of involvement: Results in eight patients
2006
Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions
2012
Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus
2005